JKHY vs VRCA · P/E 30, rev $2.54B vs rev $10.9M
Jack Henry & Associates Inc (JKHY) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
JKHY currently screens at market cap $12.76B and trailing P/E 29.8. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the JKHY and VRCA stock pages for the full models.
Not investment advice.